{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:37:29Z","timestamp":1769823449934,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15405-0","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T23:07:49Z","timestamp":1764889669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A systematic review and meta-analysis examining the relationship between hyperthyroidism or hypothyroidism and the probability of developing liver cancer"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7740-4711","authenticated-orcid":false,"given":"Omid","family":"Asbaghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6927-4059","authenticated-orcid":false,"given":"Ghazaleh","family":"Shimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1591-7319","authenticated-orcid":false,"given":"Arman","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7278-9125","authenticated-orcid":false,"given":"Hamid","family":"Zand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"10","key":"15405_CR1","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1089\/thy.2011.0087","volume":"21","author":"A Stagnaro-Green","year":"2011","unstructured":"Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21(10):1081\u2013125.","journal-title":"Thyroid"},{"issue":"3","key":"15405_CR2","first-page":"163","volume":"110","author":"T-Y Chen","year":"2017","unstructured":"Chen T-Y, Hsu C-C, Feng I-J, Wang J-J, Su S-B, Guo H-R, et al. Higher risk for thyroid diseases in physicians than in the general population: a Taiwan nationwide population-based secondary analysis study. QJM: Int J Med. 2017;110(3):163\u20138.","journal-title":"QJM: Int J Med"},{"issue":"4","key":"15405_CR3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4103\/2230-8210.113755","volume":"17","author":"AG Unnikrishnan","year":"2013","unstructured":"Unnikrishnan AG, Kalra S, Sahay RK, Bantwal G, John M, Tewari N. Prevalence of hypothyroidism in adults: an epidemiological study in eight cities of India. Indian J Endocrinol Metab. 2013;17(4):647.","journal-title":"Indian J Endocrinol Metab"},{"issue":"4","key":"15405_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1089\/thy.2012.0500","volume":"23","author":"F Brandt","year":"2013","unstructured":"Brandt F, Thvilum M, Almind D, Christensen K, Green A, Heged\u00fcs L, et al. Graves\u2019 disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study. Thyroid. 2013;23(4):408\u201313.","journal-title":"Thyroid"},{"issue":"10","key":"15405_CR5","doi-asserted-by":"publisher","first-page":"e110437","DOI":"10.1371\/journal.pone.0110437","volume":"9","author":"AS Laulund","year":"2014","unstructured":"Laulund AS, Nybo M, Brix TH, Abrahamsen B, J\u00f8rgensen HL, Heged\u00fcs L. Duration of thyroid dysfunction correlates with all-cause mortality. The OPENTHYRO register cohort. PLoS One. 2014;9(10):e110437.","journal-title":"PLoS One"},{"issue":"3","key":"15405_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/apha.12648","volume":"217","author":"D Gnocchi","year":"2016","unstructured":"Gnocchi D, Steffensen K, Bruscalupi G, Parini P. Emerging role of thyroid hormone metabolites. Acta Physiol. 2016;217(3):184\u2013216.","journal-title":"Acta Physiol"},{"issue":"3","key":"15405_CR7","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"15405_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep29258","volume":"6","author":"A Petrizzo","year":"2016","unstructured":"Petrizzo A, Caruso FP, Tagliamonte M, Tornesello ML, Ceccarelli M, Costa V, et al. Identification and validation of HCC-specific gene transcriptional signature for tumor antigen discovery. Sci Rep. 2016;6(1):1\u201312.","journal-title":"Sci Rep"},{"key":"15405_CR9","doi-asserted-by":"crossref","unstructured":"Niu J, Lin Y, Guo Z, Niu M, Su C. The epidemiological investigation on the risk factors of hepatocellular carcinoma: a case\u2013control study in Southeast China. Medicine. 2016;95(6):e2758.","DOI":"10.1097\/MD.0000000000002758"},{"key":"15405_CR10","doi-asserted-by":"crossref","unstructured":"Gionfra F, De Vito P, Pallottini V, Lin H-Y, Davis PJ, Pedersen JZ, et al. The role of thyroid hormones in hepatocyte proliferation and liver cancer. Front Endocrinol. 2019;10:532.","DOI":"10.3389\/fendo.2019.00532"},{"key":"15405_CR11","doi-asserted-by":"crossref","unstructured":"Ekinci, I. Metabolic syndrome in thyroid disease, metabolic syndrome: a comprehensive update with new insights. Bentham Sci Publishers. 2025;1:402-20.","DOI":"10.2174\/9789815322132125010026"},{"issue":"2","key":"15405_CR12","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/biof.1797","volume":"48","author":"LA Videla","year":"2022","unstructured":"Videla LA, Valenzuela RJB. Perspectives in liver redox imbalance: toxicological and pharmacological aspects underlying iron overloading, nonalcoholic fatty liver disease, and thyroid hormone action. Biofactors. 2022;48(2):400\u201315.","journal-title":"Biofactors"},{"key":"15405_CR13","doi-asserted-by":"crossref","unstructured":"Venditti P, Napolitano G, Di Meo S. Role of mitochondria and other ROS sources in hyperthyroidism-linked oxidative stress. Immunol, Endocr Metab Agents-Med Chem Curr Med Chem-Immunol, Endocr Metab Agents. 2015;15(1):5\u201336.","DOI":"10.2174\/187152221501150710124951"},{"key":"15405_CR14","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Torres M, Romero Ma, Barja GJM, endocrinology c. Effect of thyroid hormones on mitochondrial oxygen free radical production and DNA oxidative damage in the rat heart. Mol cell endocrinol. 2000;168(1\u20132):127\u201334.","DOI":"10.1016\/S0303-7207(00)00302-6"},{"key":"15405_CR15","doi-asserted-by":"crossref","unstructured":"Chng C-L, Goh GBB, Yen PMJT. Metabolic and functional cross talk between the thyroid and liver. Thyroid. 2025;35(6):607\u201323.","DOI":"10.1089\/thy.2025.0178"},{"key":"15405_CR16","doi-asserted-by":"crossref","unstructured":"Mavromati M, Jornayvaz FRJI. Hypothyroidism-associated dyslipidemia: potential molecular mechanisms leading to NAFLD. Int j mol sci. 2021;22(23):12797.","DOI":"10.3390\/ijms222312797"},{"issue":"6","key":"15405_CR17","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1111\/cas.14908","volume":"112","author":"CC Wu","year":"2021","unstructured":"Wu CC, Islam MM, Nguyen PA, Poly TN, Wang CH, Iqbal U, et al. Risk of cancer in long-term levothyroxine users: retrospective population\u2010based study. Cancer Sci. 2021;112(6):2533.","journal-title":"Cancer Sci"},{"issue":"11","key":"15405_CR18","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1530\/EC-18-0258","volume":"7","author":"J Kirkeg\u00e5rd","year":"2018","unstructured":"Kirkeg\u00e5rd J, Farkas DK, J\u00f8rgensen JOL, Cronin-Fenton DP. Hyperthyroidism or hypothyroidism and gastrointestinal cancer risk: a Danish nationwide cohort study. Endocr Connect. 2018;7(11):1129\u201335.","journal-title":"Endocr Connect"},{"issue":"7","key":"15405_CR19","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1089\/thy.2012.0568","volume":"23","author":"Y-K Chen","year":"2013","unstructured":"Chen Y-K, Lin C-L, Chang Y-J, Cheng FT-F, Peng C-L, Sung F-C, et al. Cancer risk in patients with graves\u2019 disease: a nationwide cohort study. Thyroid. 2013;23(7):879\u201384.","journal-title":"Thyroid"},{"issue":"9","key":"15405_CR20","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1038\/bjc.2013.597","volume":"109","author":"Y-K Chen","year":"2013","unstructured":"Chen Y-K, Lin C, Cheng FT, Sung F, Kao C. Cancer risk in patients with Hashimoto\u2019s thyroiditis: a nationwide cohort study. Br J Cancer. 2013;109(9):2496\u2013501.","journal-title":"Br J Cancer"},{"issue":"5","key":"15405_CR21","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/hep.22793","volume":"49","author":"MM Hassan","year":"2009","unstructured":"Hassan MM, Kaseb A, Li D, Patt YZ, Vauthey JN, Thomas MB, et al. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology. 2009;49(5):1563\u201370.","journal-title":"Hepatology"},{"issue":"1","key":"15405_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89.","journal-title":"Syst Rev"},{"issue":"9","key":"15405_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"Pt A","key":"15405_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","volume":"45","author":"R DerSimonian","year":"2015","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45(Pt A):139\u201345.","journal-title":"Contemp Clin Trials"},{"key":"15405_CR25","unstructured":"Chandler J, Cumpston M, Li T, Page MJ, Welch VJ. Cochrane handbook for systematic reviews of interventions. Hoboken: Wiley. 2019;4(1002):14651858."},{"issue":"1","key":"15405_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-70","volume":"14","author":"WA van Enst","year":"2014","unstructured":"van Enst WA, Ochodo E, Scholten RJ, Hooft L, Leeflang MM. Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological study. BMC Med Res Methodol. 2014;14(1):1\u201311.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"15405_CR27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.beem.2015.04.001","volume":"29","author":"SR Hammes","year":"2015","unstructured":"Hammes SR, Davis PJ. Overlapping nongenomic and genomic actions of thyroid hormone and steroids. Best Pract Res Clin Endocrinol Metab. 2015;29(4):581\u201393.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"15405_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrendo.2015.205","volume":"12","author":"PJ Davis","year":"2016","unstructured":"Davis PJ, Goglia F, Leonard JL. Nongenomic actions of thyroid hormone. Nat Rev Endocrinol. 2016;12(2):111\u201321.","journal-title":"Nat Rev Endocrinol"},{"key":"15405_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/nyas.12374","volume":"1311","author":"EA McAninch","year":"2014","unstructured":"McAninch EA, Bianco AC. Thyroid hormone signaling in energy homeostasis and energy metabolism. Ann N Y Acad Sci. 2014;1311:77\u201387.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"15405_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cgh.2006.07.011","volume":"5","author":"A Reddy","year":"2007","unstructured":"Reddy A, Dash C, Leerapun A, Mettler TA, Stadheim LM, Lazaridis KN, et al. Hypothyroidism: a possible risk factor for liver cancer in patients with no known underlying cause of liver disease. Clin Gastroenterol Hepatol. 2007;5(1):118\u201323.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"20","key":"15405_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20204986","volume":"20","author":"Y-C Liu","year":"2019","unstructured":"Liu Y-C, Yeh C-T, Lin K-H. Molecular functions of thyroid hormone signaling in regulation of cancer progression and anti-apoptosis. Int J Mol Sci. 2019;20(20):4986.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"15405_CR32","first-page":"603","volume":"60","author":"GM Ledda-Columbano","year":"2000","unstructured":"Ledda-Columbano GM, Perra A, Loi R, Shinozuka H, Columbano A. Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas. Cancer Res. 2000;60(3):603\u20139.","journal-title":"Cancer Res"},{"issue":"1","key":"15405_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1677\/jme.1.01911","volume":"36","author":"C-C Yen","year":"2006","unstructured":"Yen C-C, Huang Y-H, Liao C-Y, Liao C-J, Cheng W-L, Chen W-J, et al. Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta. J Mol Endocrinol. 2006;36(1):9\u201321.","journal-title":"J Mol Endocrinol"},{"issue":"8","key":"15405_CR34","doi-asserted-by":"publisher","first-page":"16240","DOI":"10.3390\/ijms140816240","volume":"14","author":"AR Brown","year":"2013","unstructured":"Brown AR, Simmen R, Simmen FA. The role of thyroid hormone signaling in the prevention of digestive system cancers. Int J Mol Sci. 2013;14(8):16240\u201357.","journal-title":"Int J Mol Sci"},{"key":"15405_CR35","doi-asserted-by":"crossref","unstructured":"Sahin T, Oral A, Turker F, Kocak E. Can hypothyroidism be a protective factor for hepatocellular carcinoma in cirrhosis? Medicine. 2020;99(11):e19492.","DOI":"10.1097\/MD.0000000000019492"},{"issue":"8","key":"15405_CR36","doi-asserted-by":"publisher","first-page":"R353","DOI":"10.1530\/ERC-16-0152","volume":"23","author":"A Perra","year":"2016","unstructured":"Perra A, Plateroti M, Columbano A. T3\/TRs axis in hepatocellular carcinoma: new concepts for an old pair. Endocr Relat Cancer. 2016;23(8):R353-69.","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"15405_CR37","doi-asserted-by":"publisher","first-page":"e0181878","DOI":"10.1371\/journal.pone.0181878","volume":"12","author":"M Pinter","year":"2017","unstructured":"Pinter M, Haupt L, Hucke F, Bota S, Bucsics T, Trauner M, et al. The impact of thyroid hormones on patients with hepatocellular carcinoma. PLoS One. 2017;12(8):e0181878.","journal-title":"PLoS One"},{"issue":"25","key":"15405_CR38","doi-asserted-by":"publisher","first-page":"15549","DOI":"10.1074\/jbc.M115.649707","volume":"290","author":"J Srivastava","year":"2015","unstructured":"Srivastava J, Robertson CL, Gredler R, Siddiq A, Rajasekaran D, Akiel MA, et al. Astrocyte elevated gene-1 (AEG-1) contributes to non-thyroidal illness syndrome (NTIS) associated with hepatocellular carcinoma (HCC). J Biol Chem. 2015;290(25):15549\u201358.","journal-title":"J Biol Chem"},{"key":"15405_CR39","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/361304","author":"MD Rosen","year":"2011","unstructured":"Rosen MD, Privalsky ML. Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis. J Thyroid Res. 2011. https:\/\/doi.org\/10.4061\/2011\/361304.","journal-title":"J Thyroid Res"},{"issue":"1","key":"15405_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0304-3835(06)80015-7","volume":"98","author":"KH Lin","year":"1995","unstructured":"Lin KH, Lin YW, Lee HF, Liu WL, Chen ST, Chang KS, et al. Increased invasive activity of human hepatocellular carcinoma cells is associated with an overexpression of thyroid hormone beta 1 nuclear receptor and low expression of the anti-metastatic nm23 gene. Cancer Lett. 1995;98(1):89\u201395.","journal-title":"Cancer Lett"},{"issue":"7","key":"15405_CR41","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1210\/endo.141.7.7570","volume":"141","author":"KH Lin","year":"2000","unstructured":"Lin KH, Shieh HY, Hsu HC. Negative regulation of the antimetastatic gene Nm23-H1 by thyroid hormone receptors. Endocrinology. 2000;141(7):2540\u20137.","journal-title":"Endocrinology"},{"issue":"1","key":"15405_CR42","first-page":"1","volume":"6","author":"T Wang","year":"2016","unstructured":"Wang T, Xia L, Ma S, Qi X, Li Q, Xia Y, et al. Hepatocellular carcinoma: thyroid hormone promotes tumorigenicity through inducing cancer stem-like cell self-renewal. Sci Rep. 2016;6(1):1\u20139.","journal-title":"Sci Rep"},{"issue":"17","key":"15405_CR43","doi-asserted-by":"publisher","first-page":"15050","DOI":"10.18632\/oncotarget.3670","volume":"6","author":"IH Chung","year":"2015","unstructured":"Chung IH, Chen CY, Lin YH, Chi HC, Huang YH, Tai PJ, et al. Thyroid hormone-mediated regulation of lipocalin 2 through the Met\/FAK pathway in liver cancer. Oncotarget. 2015;6(17):15050\u201364.","journal-title":"Oncotarget"},{"issue":"1","key":"15405_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-019-0517-x","volume":"26","author":"H-C Chi","year":"2019","unstructured":"Chi H-C, Tsai C-Y, Tsai M-M, Yeh C-T, Lin K-H. Molecular functions and clinical impact of thyroid hormone-triggered autophagy in liver-related diseases. J Biomed Sci. 2019;26(1):1\u201315.","journal-title":"J Biomed Sci"},{"key":"15405_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00174","volume":"7","author":"Y-H Lin","year":"2020","unstructured":"Lin Y-H, Lin K-H, Yeh C-T. Thyroid hormone in hepatocellular carcinoma: cancer risk, growth regulation, and anticancer drug resistance. Front Med (Lausanne). 2020;7:174.","journal-title":"Front Med (Lausanne)"},{"key":"15405_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110604","volume":"499","author":"D Gnocchi","year":"2020","unstructured":"Gnocchi D, Ellis ECS, Johansson H, Eriksson M, Bruscalupi G, Steffensen KR, et al. Diiodothyronines regulate metabolic homeostasis in primary human hepatocytes by modulating mTORC1 and mTORC2 activity. Mol Cell Endocrinol. 2020;499:110604.","journal-title":"Mol Cell Endocrinol"},{"key":"15405_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1119952","volume":"13","author":"S Incerpi","year":"2022","unstructured":"Incerpi S, Ashur-Fabian O, Davis PJ, Pedersen JZ. Editorial: crosstalk between thyroid hormones, analogs and ligands of integrin \u03b1v\u03b23 in health and disease. Who is talking now? Front Endocrinol (Lausanne). 2022;13:1119952.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"15405_CR48","doi-asserted-by":"publisher","first-page":"899","DOI":"10.21037\/tcr.2019.05.29","volume":"8","author":"J Li","year":"2019","unstructured":"Li J, Zhou P, Xu H, Tian S, Liu W, Zhao Y, et al. Antitumor activity of integrin \u03b1(V)\u03b2(3) antibody conjugated-cationic microbubbles in liver cancer. Transl Cancer Res. 2019;8(3):899\u2013908.","journal-title":"Transl Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15405-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15405-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15405-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T13:35:08Z","timestamp":1769780108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15405-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15405"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15405-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}